Skip to content
June 02, 2023


Investment information for the new generation

BioVaxys - 14-06- Press Release Thumbnails

VIDEO: BioVaxys Technology (BIOV.C) Receives Positive FDA Response

BioVaxys Technology (BIOV.C) announced today that the US Food and Drug Administration (FDA) has reviewed its pre-IND request for a Type B review of the Company’s Covid-T™ program. Read full article here:

Related Posts

More on

Leave a Reply

Your email address will not be published. Required fields are marked *